These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32146135)

  • 1. Key considerations for using pharmacogenomics to optimize pain management.
    Gammal RS; Mayes J; Caudle KE
    J Am Pharm Assoc (2003); 2020; 60(2):290-291. PubMed ID: 32146135
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacist's role in pharmacogenomics and pain management.
    Marti KE; Marti KM; Salvo MC
    J Am Pharm Assoc (2003); 2020; 60(2):290. PubMed ID: 31813751
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals.
    Ho TT; Gift M; Alexander E
    Per Med; 2022 Jan; 19(1):15-23. PubMed ID: 34881640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of pharmacogenomics into inpatient general medicine.
    Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO
    Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics: Precision Pharmacy in 503A Compounding.
    Drummond J; Bennet D; Allen LV
    Int J Pharm Compd; 2018; 22(2):95-107. PubMed ID: 29877857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists.
    Meloche M; Kwon HJ; Letarte N; Bussières JF; Vadnais B; Hurlimann T; Lavoie A; Beauchesne MF; de Denus S
    Pharmacogenomics; 2020 Mar; 21(4):235-245. PubMed ID: 32077363
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel.
    Ho TT; Bell G; Gammal RS; Gregornik D; Wake DT; Dunnenberger HM
    Am J Health Syst Pharm; 2022 Sep; 79(19):1634-1644. PubMed ID: 35876085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.
    Chenoweth MJ; Giacomini KM; Pirmohamed M; Hill SL; van Schaik RHN; Schwab M; Shuldiner AR; Relling MV; Tyndale RF
    Clin Pharmacol Ther; 2020 Jan; 107(1):57-61. PubMed ID: 31696505
    [No Abstract]   [Full Text] [Related]  

  • 15. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
    Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
    Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
    [No Abstract]   [Full Text] [Related]  

  • 19. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for pharmacogenomic testing in a health system.
    Gammal RS; Caudle KE; Klein TE; Relling MV
    Genet Med; 2019 Aug; 21(8):1886-1887. PubMed ID: 30631112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.